Literature DB >> 11382926

Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.

B Guan1, P Yue, G L Clayman, S Y Sun.   

Abstract

DR4 (TRAIL-R1), a member of the tumor necrosis factor receptor superfamily, is a cell surface receptor that triggers the apoptotic machinery upon binding to its ligand tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Although three other TRAIL receptors DR5, DcR1, and DcR2 are induced by DNA damage and are regulated by the wild-type p53 tumor suppressor, it was not known whether these factors also affect DR4 expression. In this study, we found that DR4 expression is also enhanced by DNA damage whether induced by ionizing radiation or by chemotherapeutic agents. The induction was observed predominantly in cells containing wild-type p53 and was similar to the regulation patterns of DR5 and Fas, two other members of the family which are known to be regulated by p53. Transfection of HPV 16 E6 gene into cells with wild-type p53, which decreased the level of p53 protein, resulted in suppression of DR4 induction by DNA-damaging agents. Conversely, introduction of exogenous wild-type p53 through adenovirus infection has led to upregulation of endogenous DR4 in cells with mutant p53. Moreover, the transcription inhibitor actinomycin D abolished DNA-damaging agent-induced DR4 expression. Thus, DR4 appears to be a DNA damage-inducible, p53-regulated gene. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11382926     DOI: 10.1002/jcp.1101

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

Review 1.  Resistance to TRAIL and how to surmount it.

Authors:  Danijela Maksimovic-Ivanic; Stanislava Stosic-Grujicic; Ferdinando Nicoletti; Sanja Mijatovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  TRAIL-induced apoptosis is enhanced by heat shock protein 70 expression.

Authors:  N J Clemons; R L Anderson
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

3.  GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis.

Authors:  S Kurita; J L Mott; L L Almada; S F Bronk; N W Werneburg; S-Y Sun; L R Roberts; M E Fernandez-Zapico; G J Gores
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

4.  Cleavage of p53-vimentin complex enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of rheumatoid arthritis synovial fibroblasts.

Authors:  Xinwen Yang; Jianhua Wang; Cunren Liu; William E Grizzle; Shaohua Yu; Shuangqin Zhang; Stephen Barnes; William J Koopman; John D Mountz; Robert P Kimberly; Huang-Ge Zhang
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

5.  Activation of conventional PKC isoforms increases expression of the pro-apoptotic protein Bad and TRAIL receptors.

Authors:  Buckminster Farrow; Robert P Thomas; Xiao-fu Wang; B Mark Evers
Journal:  Int J Gastrointest Cancer       Date:  2002

6.  Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics.

Authors:  Bei H Morrison; Joseph A Bauer; Jiadi Hu; Ronald W Grane; Aylin M Ozdemir; Mamta Chawla-Sarkar; Bendi Gong; Alex Almasan; Dhananjaya V Kalvakolanu; Daniel J Lindner
Journal:  Oncogene       Date:  2002-03-14       Impact factor: 9.867

7.  Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition.

Authors:  Weilong Yao; You-Take Oh; Jiusheng Deng; Ping Yue; Liang Deng; Henry Huang; Wei Zhou; Shi-Yong Sun
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

8.  Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis.

Authors:  Julie Guillermet; Nathalie Saint-Laurent; Philippe Rochaix; Olivier Cuvillier; Thierry Levade; Andrew V Schally; Lucien Pradayrol; Louis Buscail; Christiane Susini; Corinne Bousquet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-18       Impact factor: 11.205

9.  DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells.

Authors:  Joo-Young Im; Bo-Kyung Kim; Ji-Young Lee; Seung-Ho Park; Hyun Seung Ban; Kyeong Eun Jung; Misun Won
Journal:  Oncogene       Date:  2017-12-15       Impact factor: 9.867

10.  Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide.

Authors:  Shawn Hingtgen; Xianghui Ren; Ernie Terwilliger; Marie Classon; Ralph Weissleder; Khalid Shah
Journal:  Mol Cancer Ther       Date:  2008-11       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.